ES2046270T3 - Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple. - Google Patents

Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.

Info

Publication number
ES2046270T3
ES2046270T3 ES198888116540T ES88116540T ES2046270T3 ES 2046270 T3 ES2046270 T3 ES 2046270T3 ES 198888116540 T ES198888116540 T ES 198888116540T ES 88116540 T ES88116540 T ES 88116540T ES 2046270 T3 ES2046270 T3 ES 2046270T3
Authority
ES
Spain
Prior art keywords
formulation
pharmaceutical composition
multiple compression
procedure
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888116540T
Other languages
English (en)
Spanish (es)
Inventor
Norval E. Webb
Gregory V. Hammer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2046270T3 publication Critical patent/ES2046270T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES198888116540T 1987-10-07 1988-10-06 Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple. Expired - Lifetime ES2046270T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10593987A 1987-10-07 1987-10-07
US21130888A 1988-06-24 1988-06-24

Publications (1)

Publication Number Publication Date
ES2046270T3 true ES2046270T3 (es) 1994-02-01

Family

ID=26803117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888116540T Expired - Lifetime ES2046270T3 (es) 1987-10-07 1988-10-06 Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.

Country Status (18)

Country Link
EP (1) EP0311067B1 (enExample)
JP (1) JP2722219B2 (enExample)
KR (1) KR960007748B1 (enExample)
CN (1) CN1053570C (enExample)
AU (1) AU608069B2 (enExample)
CA (1) CA1314485C (enExample)
DE (1) DE3874072T2 (enExample)
DK (1) DK168270B1 (enExample)
ES (1) ES2046270T3 (enExample)
FI (1) FI89241C (enExample)
GR (1) GR3005542T3 (enExample)
HU (1) HU200916B (enExample)
IE (1) IE61130B1 (enExample)
IL (1) IL87943A (enExample)
NO (1) NO176746C (enExample)
NZ (1) NZ226482A (enExample)
PH (1) PH26155A (enExample)
PT (1) PT88682B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
CN1071570C (zh) * 1993-06-14 2001-09-26 詹森药业有限公司 阿司咪唑和假麻黄碱的缓释薄膜包衣片
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
CN1183044A (zh) * 1995-04-03 1998-05-27 中外制药株式会社 含有硫糖铝的制剂组合物
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6232351B1 (en) * 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US20020094345A1 (en) 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
JP5383514B2 (ja) * 2007-03-12 2014-01-08 ウェルズ ファーゴ バンク ナショナル アソシエイション オリゴマー−抗ヒスタミン複合体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3878217A (en) 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
JPS5788117A (en) * 1980-11-21 1982-06-01 Smithkline Corp Gelatin capsule containing triamterene
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
ZA838033B (en) * 1982-11-01 1984-06-27 Merrell Dow Pharma Sustained release solid dosage forms having non-uniform distribution of active ingredient
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
GB2142824B (en) * 1983-07-07 1987-02-11 American Home Prod Pharmaceutical composition containing a liquid lubricant

Also Published As

Publication number Publication date
DK168270B1 (da) 1994-03-07
IE61130B1 (en) 1994-10-05
CN1053570C (zh) 2000-06-21
PH26155A (en) 1992-03-18
NO176746B (no) 1995-02-13
FI884545A7 (fi) 1989-04-08
GR3005542T3 (enExample) 1993-06-07
FI884545A0 (fi) 1988-10-03
DK559088D0 (da) 1988-10-06
KR890006236A (ko) 1989-06-12
DE3874072D1 (de) 1992-10-01
NO884443D0 (no) 1988-10-06
EP0311067B1 (en) 1992-08-26
FI89241B (fi) 1993-05-31
JPH01128925A (ja) 1989-05-22
CN1032738A (zh) 1989-05-10
NZ226482A (en) 1990-09-26
IE883033L (en) 1989-04-07
CA1314485C (en) 1993-03-16
NO884443L (no) 1989-04-10
IL87943A (en) 1992-02-16
AU2345988A (en) 1989-04-20
NO176746C (no) 1995-05-24
PT88682B (pt) 1992-12-31
KR960007748B1 (ko) 1996-06-12
AU608069B2 (en) 1991-03-21
HU200916B (en) 1990-09-28
HUT48816A (en) 1989-07-28
DE3874072T2 (de) 1993-04-08
IL87943A0 (en) 1989-03-31
JP2722219B2 (ja) 1998-03-04
EP0311067A1 (en) 1989-04-12
FI89241C (fi) 1993-09-10
PT88682A (pt) 1988-11-01
DK559088A (da) 1989-04-08

Similar Documents

Publication Publication Date Title
ES2032755T3 (es) Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral.
ES2032860T3 (es) Adsorbatos medicamentosos con surfactante y su preparacion.
ES2152986T3 (es) Genoterapia de celulas mesoteliales.
ES2054813T3 (es) Formulacion de acetaminofen de liberacion sostenida por via oral y procedimiento para obtenerla.
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
ES2086542T3 (es) Procedimiento para la fabricacion de matrices de celulosa porosas.
SE8303531D0 (sv) Farmaceutisk komposition
ATE66368T1 (de) Sich schnell verfluessigende kautablette.
BR9812001A (pt) Composição farmacêutica para combinação de descongestionante piperidinoalcanol
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
OA08333A (fr) Conditionnement étanche sous forme de planquette alvéolaire permettant des échanges gazeux entre les alvéoles.
ATE101517T1 (de) Pharmazeutische zusammensetzung, enthaltend loratadin, ibuprofen und pseudoephedrin.
GB1484832A (en) Tablets
EP0021009A3 (en) Preparation for substances, process for its production and its utilisation
GB993291A (en) Tablets, pills, pellets and the like
ES2098930T3 (es) Micropastillas de retardo de derivados de beta-fenilpropiofenona.
ES2164283T3 (es) Indanilidinacetilguanidinas sustituidas como inhibidores del intercambio de na+/h+, procedimiento para su preparacion, su uso como medicamentos o agentes de diagnostico y medicamentos que las contienen.
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
GB1341376A (en) Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole
AR030647A1 (es) Composicion farmaceutica con actividad de agua especifica
GB1327560A (en) Effervescent pharmaceutical preparations
GB1013578A (en) Analgesic composition
ES2127305T3 (es) Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos.
ES2094566T3 (es) Nuevas formulaciones farmaceuticas de espiramicina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311067

Country of ref document: ES